Lcal administration of 1 per cent Ubretid in the handling of glaucoma, myasthenia gravis and esotropia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage* / Q000494:pharmacology; D003231:Conjunctivitis / Q000139:chemically induced; D004456:Echothiophate Iodide / Q000627:therapeutic use; D005094:Exophthalmos / Q000188:drug therapy; D005133:Eye Movements / Q000187:drug effects; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D013285:Strabismus / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors; D009883:Ophthalmic Solutions; D000644:Quaternary Ammonium Compounds; D004456:Echothiophate Iodide